References
- Wynn TA, Chawla A and Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496, 445-455 https://doi.org/10.1038/nature12034
- Pollard JW (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9, 259-270 https://doi.org/10.1038/nri2528
- Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3, 23-35 https://doi.org/10.1038/nri978
- Mosser DM and Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958-969 https://doi.org/10.1038/nri2448
- Mosser DM and Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226, 205-218 https://doi.org/10.1111/j.1600-065X.2008.00706.x
- Jenkins SJ, Ruckerl D, Cook PC et al (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332, 1284-1288 https://doi.org/10.1126/science.1204351
- Poon IK, Lucas CD, Rossi AG and Ravichandran KS (2014) Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 14, 166-180 https://doi.org/10.1038/nri3607
- Amano SU, Cohen JL, Vangala P et al (2014) Local proliferation of macrophages contributes to obesityassociated adipose tissue inflammation. Cell Metab 19, 162-171 https://doi.org/10.1016/j.cmet.2013.11.017
- Kim DI, Kim E, Kim YA, Cho SW, Lim JA and Park YJ (2016) Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer. Endocrinol Metab (Seoul) 31, 469-475 https://doi.org/10.3803/EnM.2016.31.3.469
- Mielgo A and Schmid MC (2013) Impact of tumour associated macrophages in pancreatic cancer. BMB Rep 46, 131-138 https://doi.org/10.5483/BMBRep.2013.46.3.036
- Oh BC, Kim HJ (2010) Magnetic resonance imaging contrast agent with paramagnetic-inositol phosphates complexes. US 12/656,075
- Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J and Sambhara S (2002) Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 169, 4697-4701 https://doi.org/10.4049/jimmunol.169.9.4697
- Moore KW, de Waal Malefyt R, Coffman RL and O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765 https://doi.org/10.1146/annurev.immunol.19.1.683
- Thangarajh M, Gomes A, Masterman T, Hillert J and Hjelmstrom P (2004) Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis. J Neuroimmunol 152, 183-190 https://doi.org/10.1016/j.jneuroim.2004.03.017
- Zimmermann VS, Rovere P, Trucy J et al (1999) Engagement of B cell receptor regulates the invariant chain-dependent MHC class II presentation pathway. J Immunol 162, 2495-2502
- Shachar I and Flavell RA (1996) Requirement for invariant chain in B cell maturation and function. Science 274, 106-108 https://doi.org/10.1126/science.274.5284.106
- Lauber K, Blumenthal SG, Waibel M and Wesselborg S (2004) Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 14, 277-287 https://doi.org/10.1016/S1097-2765(04)00237-0
- Segawa K, Kurata S, Yanagihashi Y, Brummelkamp TR, Matsuda F and Nagata S (2014) Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science 344, 1164-1168 https://doi.org/10.1126/science.1252809
- Yoon KW, Byun S, Kwon E et al (2015) Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science 349, 1261669 https://doi.org/10.1126/science.1261669
- Arandjelovic S and Ravichandran KS (2015) Phagocytosis of apoptotic cells in homeostasis. Nat Immunol 16, 907-917 https://doi.org/10.1038/ni.3253
- Gregory CD (2000) CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr Opin Immunol 12, 27-34 https://doi.org/10.1016/S0952-7915(99)00047-3
- Linehan E, Dombrowski Y, Snoddy R, Fallon PG, Kissenpfennig A and Fitzgerald DC (2014) Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis. Aging Cell 13, 699-708 https://doi.org/10.1111/acel.12223
- Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J and Sambhara S (2004) Innate immunity in aging: impact on macrophage function. Aging Cell 3, 161-167 https://doi.org/10.1111/j.1474-9728.2004.00102.x
- Ghesquiere B, Wong BW, Kuchnio A and Carmeliet P (2014) Metabolism of stromal and immune cells in health and disease. Nature 511, 167-176 https://doi.org/10.1038/nature13312
- Popi AF, Lopes JD and Mariano M (2004) Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro. Immunology 113, 348-354 https://doi.org/10.1111/j.1365-2567.2004.01969.x
- Amir O, Spivak I, Lavi I and Rahat MA (2012) Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients. Mediators Inflamm 2012, 616384
- Sakai K, Hasebe R, Takahashi Y et al (2013) Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation. J Virol 87, 13433-13445 https://doi.org/10.1128/JVI.02072-13
- Kim OH, Kim YO, Shim JH et al (2010) beta-propeller phytase hydrolyzes insoluble Ca(2+)-phytate salts and completely abrogates the ability of phytate to chelate metal ions. Biochemistry 49, 10216-10227 https://doi.org/10.1021/bi1010249
- Lee YJ, Lee YJ and Lee SH (2015) Resveratrol and clofarabine induces a preferential apoptosis-activating effect on malignant mesothelioma cells by Mcl-1 down-regulation and caspase-3 activation. BMB Rep 48, 166-171 https://doi.org/10.5483/BMBRep.2015.48.3.105
Cited by
- The physiology of foamy phagocytes in multiple sclerosis vol.6, pp.1, 2018, https://doi.org/10.1186/s40478-018-0628-8